Mitch Maloy

Affiliations: 
2018-2020 Chemical and Biological Engineering State University of New York, Buffalo, Buffalo, NY, United States 
Google:
"Mitch Maloy"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Tamari R, Brown S, Devlin SM, et al. (2021) Fractionated Infusion of Hematopoietic Progenitor Cells Does Not Improve Neutrophil Recovery or Survival in Allograft Recipients. Transplantation and Cellular Therapy
Brambilla CZ, Lobaugh SM, Ruiz JD, et al. (2021) Relapse after allogeneic stem cell transplantation of acute myeloid leukemia and myelodysplastic syndrome and importance of second cellular therapy. Transplantation and Cellular Therapy
Ogoke O, Maloy M, Parashurama N. (2020) The science and engineering of stem cell-derived organoids-examples from hepatic, biliary, and pancreatic tissues. Biological Reviews of the Cambridge Philosophical Society
Maloy MH, Ferrer MA, Parashurama N. (2020) In Vivo Differentiation of Stem Cell-derived Human Pancreatic Progenitors to Treat Type 1 Diabetes. Stem Cell Reviews and Reports
Cerrano M, Ruella M, Perales MA, et al. (2020) The Advent of CAR T-Cell Therapy for Lymphoproliferative Neoplasms: Integrating Research Into Clinical Practice. Frontiers in Immunology. 11: 888
Lin RJ, Ho C, Devlin SM, et al. (2020) Impact of allogeneic hematopoietic cell transplantation on immune evasive mechanisms in relapsed refractory large B-cell lymphoma. Bone Marrow Transplantation
Lin A, Maloy M, Su Y, et al. (2019) Letermovir for primary and secondary cytomegalovirus prevention in allogeneic hematopoietic cell transplant recipients: real world experience. Transplant Infectious Disease : An Official Journal of the Transplantation Society. e13187
Bryant AR, Hilden P, Giralt S, et al. (2019) Pre-salvage ISS and Other Important Outcome Associations in CD34 Selected Allogeneic Hematopoietic Stem Cell Transplant for Multiple Myeloma. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation
Jain T, Sauter CS, Shah GL, et al. (2019) Safety and feasibility of chimeric antigen receptor T cell therapy after allogeneic hematopoietic cell transplantation in relapsed/ refractory B cell non-Hodgkin lymphoma. Leukemia
Malard F, Labopin M, Cho C, et al. (2018) Ex vivo and in vivo T cell-depleted allogeneic stem cell transplantation in patients with acute myeloid leukemia in first complete remission resulted in similar overall survival: on behalf of the ALWP of the EBMT and the MSKCC. Journal of Hematology & Oncology. 11: 127
See more...